Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R01AR087482-01
Azathioprine Safety and Pharmacokinetics in Pregnant Women with Rheumatic Disease and their Infants
Recipient
Duke University
Award Amount
$658,859.00
Ceiling
$658,859.00
Awarded
July 07, 2026
Identifier
1R01AR087482-01
A research project funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to study the safety and pharmacokinetics of Azathioprine in pregnant women with rheumatic disease and their infants, aiming to improve clinical dosing guidelines.
Description
This project involves a prospective observational study on the safety and pharmacokinetics of Azathioprine in pregnant women with autoimmune diseases, including data collection on infant outcomes and maternal safety. The funding is provided by NIAMS under the PA-25-301 grant. The project aims to establish safe dosing guidelines and improve clinical practice for pregnant women on AZA.